Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 608

1.

Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL.

Head Neck. 2005 Oct;27(10):843-50.

PMID:
16161069
[PubMed - indexed for MEDLINE]
2.

Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?

Bernier J, Cooper JS.

Oncologist. 2005 Mar;10(3):215-24. Review.

PMID:
15793225
[PubMed - indexed for MEDLINE]
Free Article
3.

Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.

Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T, Welsh J, Cohen D, Hamilton R, Nguyen N, Nguyen LM, Vinh-Hung V.

Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.

PMID:
18841033
[PubMed - indexed for MEDLINE]
4.

Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study.

Chougule PB, Suk S, Chu QD, Leone L, Nigri PT, McRae R, Lekas M, Barone A, Bhat D, Bellino J.

Cancer. 1994 Oct 1;74(7):1927-32.

PMID:
8082098
[PubMed - indexed for MEDLINE]
5.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
[PubMed - indexed for MEDLINE]
6.

Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.

Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):777-82.

PMID:
9128951
[PubMed - indexed for MEDLINE]
7.

Adjuvant therapy in patients with resected poor-risk head and neck cancer.

Bernier J, Vermorken JB, Koch WM.

J Clin Oncol. 2006 Jun 10;24(17):2629-35. Review.

PMID:
16763276
[PubMed - indexed for MEDLINE]
8.

Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.

Kuhnt T, Mueller AC, Pelz T, Haensgen G, Bloching M, Koesling S, Schubert J, Dunst J.

J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. Epub 2005 Nov 1.

PMID:
16088405
[PubMed - indexed for MEDLINE]
9.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

Fu KK, Cooper JS, Marcial VA, Laramore GE, Pajak TF, Jacobs J, Al-Sarraf M, Forastiere AA, Cox JD.

Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):425-38.

PMID:
8655364
[PubMed - indexed for MEDLINE]
10.

Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?

Cooper JS, Pajak TF, Forastiere A, Jacobs J, Fu KK, Ang KK, Laramore GE, Al-Sarraf M.

Head Neck. 1998 Oct;20(7):588-94.

PMID:
9744457
[PubMed - indexed for MEDLINE]
11.

Radiotherapeutic management of locally advanced head and neck cancer.

Laskar SG, Agarwal JP, Srinivas C, Dinshaw KA.

Expert Rev Anticancer Ther. 2006 Mar;6(3):405-17. Review.

PMID:
16503857
[PubMed - indexed for MEDLINE]
12.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Epub 2007 May 4. Review.

PMID:
17482300
[PubMed - indexed for MEDLINE]
14.

Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.

Franchin G, Minatel E, Politi D, Gobitti C, Talamini R, Vaccher E, Savignano MG, Trovo M, Sulfaro S, Barzan L.

Cancer. 2009 Jun 1;115(11):2464-71. doi: 10.1002/cncr.24252.

PMID:
19280588
[PubMed - indexed for MEDLINE]
Free Article
15.

Intraoperative radiation therapy in the multimodality approach to upper aerodigestive tract cancer.

Carter YM, Jablons DM, DuBois JB, Thomas CR Jr.

Surg Oncol Clin N Am. 2003 Oct;12(4):1043-63. Review.

PMID:
14989132
[PubMed - indexed for MEDLINE]
16.

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.

Porceddu SV, Campbell B, Rischin D, Corry J, Weih L, Guerrieri M, Grossi M, Peters LJ.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):365-73.

PMID:
15380568
[PubMed - indexed for MEDLINE]
17.

The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03.

Aref A, Berkey BA, Schwade JG, Ensley J, Schuller DE, Haselow RE, Ervin TJ, Laramore GE.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):389-94.

PMID:
10802364
[PubMed - indexed for MEDLINE]
18.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1198-205. doi: 10.1016/j.ijrobp.2012.05.008. Epub 2012 Jun 30.

PMID:
22749632
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Current trials and new aspects in soft tissue sarcoma of adults.

Issels RD, Schlemmer M.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S4-8. Epub 2002 Apr 16. Review.

PMID:
12042982
[PubMed - indexed for MEDLINE]
20.

Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.

Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M.

Int J Radiat Oncol Biol Phys. 1992;23(4):737-42.

PMID:
1618666
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk